Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP458531.RAfNmKQXSEPQRnaxeSmg3t8y2u3yiTTmXD9WtrbUMmwp4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP458531.RAfNmKQXSEPQRnaxeSmg3t8y2u3yiTTmXD9WtrbUMmwp4130_assertion type Assertion NP458531.RAfNmKQXSEPQRnaxeSmg3t8y2u3yiTTmXD9WtrbUMmwp4130_head.
- NP458531.RAfNmKQXSEPQRnaxeSmg3t8y2u3yiTTmXD9WtrbUMmwp4130_assertion description "[Comparison of the methylation level for the matched benign and prostate cancer tissues from individual patients with prostate cancer showed significantly higher methylation in the prostate cancer tissue samples for RARbeta2 (P < 0.001), RASSF1A (P = 0.005), GSTP1 (P < 0.001), NKX2-5 (P = 0.003), ESR1 (P = 0.016), and CLSTN1 (P = 0.01).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP458531.RAfNmKQXSEPQRnaxeSmg3t8y2u3yiTTmXD9WtrbUMmwp4130_provenance.
- NP458531.RAfNmKQXSEPQRnaxeSmg3t8y2u3yiTTmXD9WtrbUMmwp4130_assertion evidence source_evidence_literature NP458531.RAfNmKQXSEPQRnaxeSmg3t8y2u3yiTTmXD9WtrbUMmwp4130_provenance.
- NP458531.RAfNmKQXSEPQRnaxeSmg3t8y2u3yiTTmXD9WtrbUMmwp4130_assertion SIO_000772 17606710 NP458531.RAfNmKQXSEPQRnaxeSmg3t8y2u3yiTTmXD9WtrbUMmwp4130_provenance.
- NP458531.RAfNmKQXSEPQRnaxeSmg3t8y2u3yiTTmXD9WtrbUMmwp4130_assertion wasDerivedFrom befree-20140225 NP458531.RAfNmKQXSEPQRnaxeSmg3t8y2u3yiTTmXD9WtrbUMmwp4130_provenance.
- NP458531.RAfNmKQXSEPQRnaxeSmg3t8y2u3yiTTmXD9WtrbUMmwp4130_assertion wasGeneratedBy ECO_0000203 NP458531.RAfNmKQXSEPQRnaxeSmg3t8y2u3yiTTmXD9WtrbUMmwp4130_provenance.